Literature DB >> 17105291

Enantioselective synthesis of N1999A2.

Nan Ji1, Hardwin O'Dowd, Brad M Rosen, Andrew G Myers.   

Abstract

An enantioselective synthetic route to the enediyne antibiotic N1999A2 (1) is described, proceeding in 21 steps (0.4% yield, 77% average yield per step) from (R)-(+)-glycidol. The route involves the convergent assembly of three components: a (1-iodovinyl) stannane (2), a 1,5-hexadiyne-3,4-diol derivative (3), and a substituted naphthoic acid (4). Important transformations in the synthetic sequence include the palladium-catalyzed coupling of 2 and 3, an intramolecular oxidative cyclization of a terminal bisacetylene, and a transannular anionic (bi)cyclization of a cyclic bromoenetriyne. The careful selection and manipulation of protective groups throughout the sequence proved to be critical to the development of the synthetic route, where all late-stage intermediates were unstable and could not be concentrated. In the final step of the sequence, three protective groups were removed in a single operation, providing synthetic N1999A2 (1) in 76% yield. Conditions were found that, for the first time, led to the precipitation of 1 as a solid.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105291      PMCID: PMC2525511          DOI: 10.1021/ja0662467

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  6 in total

1.  Investigation of the total synthesis of N1999-A2: implication of stereochemistry.

Authors:  S Kobayashi; R S Reddy; Y Sugiura; D Sasaki; N Miyagawa; M Hirama
Journal:  J Am Chem Soc       Date:  2001-03-28       Impact factor: 15.419

2.  The first total synthesis of N1999-A2: absolute stereochemistry and stereochemical implications into DNA cleavage.

Authors:  S Kobayashi; S Ashizawa; Y Takahashi; Y Sugiura; M Nagaoka; M J Lear; M Hirama
Journal:  J Am Chem Soc       Date:  2001-11-14       Impact factor: 15.419

3.  DNA cleavage characteristics of non-protein enediyne antibiotic N1999A2.

Authors:  Naoko Miyagawa; Daisuke Sasaki; Mieko Matsuoka; Miki Imanishi; Toshihiko Ando; Yukio Sugiura
Journal:  Biochem Biophys Res Commun       Date:  2003-06-20       Impact factor: 3.575

4.  Enantioselective synthesis of kedarcidin chromophore aglycon in differentially protected form.

Authors:  Andrew G Myers; Philip C Hogan; Alexander R Hurd; Steven D Goldberg
Journal:  Angew Chem Int Ed Engl       Date:  2002-03-15       Impact factor: 15.336

5.  Hydrozirconation of stannylacetylenes: a novel and highly efficient synthesis of 1,1-diiodo-, 1,1-dibromo-, and mixed (Z)- or (E)-1-iodo-1-bromo-1-alkenes using 1,1-hetero-bimetallic reagents.

Authors:  M J Dabdoub; V B Dabdoub; A C Baroni
Journal:  J Am Chem Soc       Date:  2001-10-03       Impact factor: 15.419

6.  Method for the rapid synthesis of highly functionalized 2-hydroxy-1-naphthoates. Syntheses of the naphthoic acid components of neocarzinostatin chromophore and N1999A2.

Authors:  Nan Ji; Brad M Rosen; Andrew G Myers
Journal:  Org Lett       Date:  2004-11-25       Impact factor: 6.005

  6 in total
  4 in total

1.  Overriding Felkin control: a general method for highly diastereoselective chelation-controlled additions to alpha-silyloxy aldehydes.

Authors:  Gretchen R Stanton; Corinne N Johnson; Patrick J Walsh
Journal:  J Am Chem Soc       Date:  2010-03-31       Impact factor: 15.419

2.  Development of enantioselective synthetic routes to (-)-kinamycin F and (-)-lomaiviticin aglycon.

Authors:  Christina M Woo; Shivajirao L Gholap; Liang Lu; Miho Kaneko; Zhenwu Li; P C Ravikumar; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2012-10-03       Impact factor: 15.419

3.  Reaction discovery employing macrocycles: transannular cyclizations of macrocyclic bis-lactams.

Authors:  Chong Han; Sathish Rangarajan; Alicia C Voukides; Aaron B Beeler; Richard Johnson; John A Porco
Journal:  Org Lett       Date:  2009-01-15       Impact factor: 6.005

4.  Inspirations, discoveries, and future perspectives in total synthesis.

Authors:  K C Nicolaou
Journal:  J Org Chem       Date:  2009-02-06       Impact factor: 4.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.